Verici Dx Share News (VRCI)
VRCI Share
VRCI Share
VRCI Share
VRCI Share
VRCI
VRCI Share
VRCI Level 2
VRCI Live
VRCI Broker
VRCI Directors
VRCI Financial
VRCI
VRCI Short
VRCI
Last checked at -
(Sharecast News) - Organ transplant diagnostics developer Verici Dx announced on Tuesday that patient enrolment for a multi-centre observational clinical validation study for its lead products had concluded ahead of management expectations.
Read more
EXECUTIVE CHANGES: Umuthi Healthcare taps CFO as shares stay suspended
Read moreTRADING UPDATES: Robert Walters delivers record performance; FRP grows
Read moreTRADING UPDATES: Boku interim revenue up; Arena Events wins new deal
Read moreEXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO
Read moreTRADING UPDATES: STV looks to summer's football; In The Style sales up
Read moreVerici Dx remains optimistic despite USD4.7 million pretax loss
Read moreUK earnings, trading statements calendar - next 7 days
Read moreTRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US
Read moreIN BRIEF: Verici Dx Hires New Vice President Of Quality & Regulatory
Read moreIN BRIEF: Verici Dx Expands Scope Of Mount Sinai Licence Agreement
Read moreUK EXECUTIVE CHANGE SUMMARY: United Oil & Gas Hires Former Tullow CFO
Read moreVerici Dx Kicks Off AIM Trading After GBP14.5 Million Float
Read more
Last checked at